Imperial Innovations pulls in £30 million from EIB to invest in biotech
AIM-listed investment firm Imperial Innovations Group has secured a £30 million loan so that it can make investments in the biotech and therapeutics sectors.
News
AIM-listed investment firm Imperial Innovations Group has secured a £30 million loan so that it can make investments in the biotech and therapeutics sectors.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software